442 related articles for article (PubMed ID: 16374460)
1. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.
Lohwasser C; Neureiter D; Weigle B; Kirchner T; Schuppan D
J Invest Dermatol; 2006 Feb; 126(2):291-9. PubMed ID: 16374460
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
3. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products affect growth and function of osteoblasts.
Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
[TBL] [Abstract][Full Text] [Related]
5. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
6. Effects of extracellular matrix glycosylation on proliferation and apoptosis of human dermal fibroblasts via the receptor for advanced glycosylated end products.
Niu Y; Xie T; Ge K; Lin Y; Lu S
Am J Dermatopathol; 2008 Aug; 30(4):344-51. PubMed ID: 18645306
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-κB in gingival connective tissue.
Yu S; Li H; Ma Y; Fu Y
J Periodontol; 2012 Jan; 83(1):119-26. PubMed ID: 21563948
[TBL] [Abstract][Full Text] [Related]
8. Role of the receptor for advanced glycation end products in hepatic fibrosis.
Lohwasser C; Neureiter D; Popov Y; Bauer M; Schuppan D
World J Gastroenterol; 2009 Dec; 15(46):5789-98. PubMed ID: 19998499
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of dietary advanced glycation end products in rats.
Poulsen MW; Andersen JM; Hedegaard RV; Madsen AN; Krath BN; Monošík R; Bak MJ; Nielsen J; Holst B; Skibsted LH; Larsen LH; Dragsted LO
Br J Nutr; 2016 Feb; 115(4):629-36. PubMed ID: 26824730
[TBL] [Abstract][Full Text] [Related]
10. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells.
Rashid G; Benchetrit S; Fishman D; Bernheim J
Kidney Int; 2004 Sep; 66(3):1099-106. PubMed ID: 15327404
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts.
Li DX; Deng TZ; Lv J; Ke J
Braz J Med Biol Res; 2014 Dec; 47(12):1036-43. PubMed ID: 25387669
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats.
Umadevi S; Gopi V; Elangovan V
Chem Biol Interact; 2014 Feb; 208():28-36. PubMed ID: 24309158
[TBL] [Abstract][Full Text] [Related]
13. Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins.
Wondrak GT; Roberts MJ; Jacobson MK; Jacobson EL
J Invest Dermatol; 2002 Aug; 119(2):489-98. PubMed ID: 12190875
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
[TBL] [Abstract][Full Text] [Related]
16. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
Owen WF; Hou FF; Stuart RO; Kay J; Boyce J; Chertow GM; Schmidt AM
Kidney Int; 1998 May; 53(5):1365-73. PubMed ID: 9573554
[TBL] [Abstract][Full Text] [Related]
17. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
Boulanger E; Wautier MP; Wautier JL; Boval B; Panis Y; Wernert N; Danze PM; Dequiedt P
Kidney Int; 2002 Jan; 61(1):148-56. PubMed ID: 11786095
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
Berrou J; Tostivint I; Verrecchia F; Berthier C; Boulanger E; Mauviel A; Marti HP; Wautier MP; Wautier JL; Rondeau E; Hertig A
Int J Mol Med; 2009 Apr; 23(4):513-20. PubMed ID: 19288028
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.
Lieuw-a-Fa ML; Schalkwijk CG; Engelse M; van Hinsbergh VW
Thromb Haemost; 2006 Feb; 95(2):320-8. PubMed ID: 16493495
[TBL] [Abstract][Full Text] [Related]
20. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis.
Davies CA; Herrick AL; Cordingley L; Freemont AJ; Jeziorska M
Rheumatology (Oxford); 2009 Aug; 48(8):876-82. PubMed ID: 19542215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
